MiRNAs dysregulated in triple-negative breast cancer
作者： Jennifer Richer , Dawn Cochrane , Steven M. Anderson
DOI:
关键词:
摘要: The invention provides methods of diagnosing and treating cancer in a subject. inventors have identified series dysregulated miRNAs that are indicative triple-negative breast cancer. In some embodiments, the further for administration therapy to
lens.org 参考文章(9)
Valeria Ossovskaya, Barry M. Sherman, Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof ,(2007)
Riccardo Dalla-Favera, Andrea Califano, Tissue-specific micrornas and compositions and uses thereof ,(2010)
David M. Shanahan, Donald Rao, Phillip B. Maples, Neil Senzer, I John J. Nemunaitis, Individualized cancer therapy ,(2013)
Lubna Patrawala, Jason Wiggins, Andreas G. Bader, Dean G. Tang, Stephanie Volz, Can Liu, David Brown, Jeffrey Shelton, Kevin Kelnar, Methods and Compositions Involving miRNAs In Cancer Stem Cells ,(2009)
Biljana Culjkovic, Gordon A Jamieson, Alex Kentsis, Katherine L B Borden, Translational dysfunction based therapeutics ,(2006)
Dawn R. Cochrane, Diana M. Cittelly, Erin N. Howe, Nicole S. Spoelstra, Erin L. McKinsey, Kelly LaPara, Anthony Elias, Douglas Yee, Jennifer K. Richer, MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer Hormones and Cancer. ,vol. 1, pp. 306- 319 ,(2010) , 10.1007/S12672-010-0043-5
Sakari Kauppinen, Joacim Elmén, Phil Kearney, Pharmaceutical Composition Comprising Anti-Mirna Antisense Oligonucleotides ,(2007)
Blenkiron C Goldstein LD Thorne NP, Spiteri I Chin SF, None, MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Genome Biology. ,vol. 8, pp. 1- 16 ,(2007) , 10.1186/GB-2007-8-10-R214
Sofia Gruvberger-Saal, Lao Saal, Ake Borg, Ramon Parsons, Pten compositions and methods for detecting breast cancer ,(2007)